Generex Launches Generex Oral-lyn(TM) in Algeria
October 16, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 16, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Announces USFDA Price Approval for Generex Oral-lyn(TM) in the Treatment IND Program
October 14, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 14, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Biotechnology to Hold Conference Call On Thursday to Update Investors On Generex Oral-lyn(TM) and Other Corporate Activities
October 14, 2009 08:00 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 14, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Homeland Security TV Features Generex Executive to Discuss H1N1 Preparedness and Related Biological Security Issues
October 05, 2009 09:15 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Oct. 5, 2009 (GLOBE NEWSWIRE) -- Dr. Eric von Hofe, PhD, President of Antigen Express, Inc. (www.antigenexpress.com), the wholly-owned immunotherapeutics subsidiary of Generex...
Generex Presents Abstracts At Scientific Symposium in Europe
September 30, 2009 09:00 ET
|
Generex Biotechnology Corp.
45th Annual Meeting of the European Association for the Study of Diabetes
Vienna, Austria, 29 September - 2 October, 2009
WORCESTER, Mass., Sept. 30, 2009 (GLOBE NEWSWIRE) --...
Generex MENA Broadens International Reach
September 22, 2009 10:54 ET
|
Generex Biotechnology Corp.
The Company's Branch Office in the United Arab Emirates Begins
Implementing Distribution Networks Outside of the Middle East and
North Africa
...
Generex to Raise $12,250,000 in Registered Direct Offering
September 14, 2009 07:45 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Sept. 14, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Announces USFDA Approval of Use of Company's Flagship Buccal Insulin Product, Generex Oral-lyn(TM), Under the USFDA'S Treatment Investigational New Drug (IND) Program
September 10, 2009 09:00 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Sept. 10, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex to Present At Rodman & Renshaw Annual Global Investment Conference
September 08, 2009 10:18 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Sept. 8, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Establishes European Subsidiary
September 02, 2009 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., Sept. 2, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...